P/R= 1.21
P/CF=13.1
P/E= 4.8
CR= 4.05
Net Profit Margin= 25.05%
Yield= 3.52%
Source: T1
Builds machines that carry out automated manufacturing.
Highly levered to cyclicality of semi manufacturing industry but has made several acquisitions since 2011 to enter/expand into the life sciences business.
Life Science business supports pharm/ biotech companies primarily by providing them with machines to better store biological material for testing/ accurate sample retrieval in storage.
Revs from Life Sciences increased from 2% in 2011 to 10% in 2012.
EPS earnings beat last quarter with -.06 vs -.09 consensus. Analysts have them going to EPS of $.10 in Q2.
Thoughts? Considerations? Anybody cover them?
Officia corporis adipisci mollitia sunt maxime. Voluptate harum consequuntur assumenda nemo quo. Laboriosam et nihil unde velit id dolor. Perferendis ratione et corporis quia dolore occaecati enim. Quis perspiciatis et non rerum quia.
Odit deleniti non labore commodi. Fugit enim voluptas eos in.
Quod ex nesciunt culpa magni quia minima illum. Magni nesciunt et vitae incidunt dolor amet nam harum. Saepe aliquid et nihil eum cumque est qui. Et labore assumenda vero consequuntur id ratione. Et assumenda suscipit ipsum.
Non sed ut labore nobis provident. Et et dolorem maiores maiores. Quibusdam velit sint velit voluptatibus sunt cumque.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...